DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

46.94 -1.05 (-2.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ENTA $46.94 -2.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.55
Previous Close $47.99
Daily Range $46.51 - $49.09
52-Week Range $25.38 - $49.09
Market Cap $872.3M
P/E Ratio 26.66
Dividend (Yield) $0.00 (0.0%)
Volume 256,404
Average Daily Volume 340,223
Current FY EPS $9.29

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

News & Commentary

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.

AbbVie isn't conceding defeat in the next-generation hepatitis C drug race. Here's why.

Enanta Pharmaceuticals (ENTA) Reaches New Lifetime High Today

Very Exciting Days Are In Store For Enanta Stockholders

Company News for November 25, 2014 - Corporate Summary

Enanta Pharmaceutical's (ENTA) CEO Jay Luly on Q4 2014 Results - Earnings Call Transcript

Can Partnering To Fight Hepatitis C Pay At Enanta?

Health Care Sector Update for 11/24/2014: TTPH, ENTA

5 Earnings Short-Squeeze Plays

Enanta And AbbVie's ABT-450 Likely To Receive FDA Approval

Enanta Announces Results From Phase 2b PEARL-I Study In Genotype 4 Chronic Hepatitis C Patients At T

Enanta Announces Results From Phase 2b PEARL-I Study In Genotype 4 Chronic Hepatitis C Patients At The Liver Meeting 2014

See More ENTA News...